The Effect of Education Given to Patients With Heart Failure on Self-care, Drug Compliance and Quality of Life.

Sponsor
Harran University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05418478
Collaborator
(none)
80
1
2
8.1
9.8

Study Details

Study Description

Brief Summary

This study was planned as a randomized, controlled, experimental study to evaluate the effects of transtheoretic model-based education on self-care, drug compliance and quality of life in patients with heart failure. The number of samples required for the study was determined by the power analysis made in the GPower 3.1 package program. Assuming that there may be losses in follow-up and considering that non-parametric tests can be performed, the research group will consist of a total of 72 people, 36 in each group, with an increase of 20%. Patients with heart failure who do not have communication barriers to affect cognitive functions, can use tele-health applications (Smartphone and application), volunteers aged 18 and over and agree to participate in the study will be included in the intervention and control groups. The data of the study, "Socio-demographic Characteristic Data Form", "Question Form Regarding the Disease", "European Heart Failure Self-Care Behaviors Scale-12", "Beliefs About Medication Adherence Scale," in which socio-demographic characteristics and information about the disease were questioned. (IUHIO)'' and ''Minnesota Life with Heart Failure Questionnaire''.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intervention transtheoretical model group
N/A

Detailed Description

The patients in the intervention group will be trained through tele-health practices for at least 25-30 minutes on a transtheoretical basis, every 2 weeks in the 1st month and once a month in the following months. Tele-health applications include phone monitoring, SMS notification and application applications. Educational topics based on model-based self-care behaviors; It will include regular exercise, nutrition-weight monitoring, fluid intake-edema control, smoking cessation, regular drug use, regular rest, vaccination. Educational principles will be shared with patients by SMS from time to time during the education process. Treatment compliance levels and self-care behaviors of both groups of patients will be re-measured from the first week to the 6th month after the training, and any difference will be analyzed using statistical methods.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Parallel AssignmentParallel Assignment
Masking:
Double (Participant, Investigator)
Masking Description:
Intervention Model: Parallel Assignment Masking: Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
The Effect of Training Given to Patients With Heart Failure Through Transtheoretic Model-based Telehealth Methods on Self-care, Drug Adherence and Quality of Life
Actual Study Start Date :
Jun 7, 2022
Anticipated Primary Completion Date :
Jan 10, 2023
Anticipated Study Completion Date :
Feb 10, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

Study group intervention: 7 sessions of transtheoretical model-based interview (2 in the first month, a total of 7 times, once a month), a structured disease education through transtheoretical model-based telehealth practices, and 6-month follow-up. After the participants are included in the study, a health education structured according to the Transtheoretical model will be given to the patients in the study group through tele-health applications. The patients in the intervention group will be trained through tele-health practices for at least 25-30 minutes on a transtheoretical basis, every 2 weeks in the first month and once a month in the following months. Tele-health applications include phone monitoring, SMS notification and application applications. In the 6-month follow-up, there will be 2 follow-ups as pre-test (1st month) and post-test (6th month). Behavioral: 7 sessions of behavior change training based on the transtoerytic model

Behavioral: Intervention transtheoretical model group
The Transtheoretical Model is a conscious behavior modification model that focuses on individual decision making and planning processes. It is the only model that examines behavior change as a dynamic process rather than an outcome, and considers behavioral strategies that include the individual's cognitive and behavioral processes in this process. In the model, it is stated that behavior change is a process and develops gradually. It is reported that the change in the behavior of individuals consists of six stages: 1) not thinking, 2) thinking, 3) preparation, 4) taking action, 5) maintaining and 6) terminating. This model consists of four main constructs called change stages (time-related dimension), change processes/behavior modification methods (independent variable dimension), self-efficacy (levels of change) and decision-making balance (perceptions of harm and benefit of change).

No Intervention: Control

No notification will be made to the relatives of the patients in the control group. Control group patients will be called for routine control in line with their usual plans. After a total of 6 months from the beginning, the self-care and treatment compliance levels of the patients in the control group will be examined. There will be 2 follow-ups as pre-test (1st month) and post-test (6th month).

Outcome Measures

Primary Outcome Measures

  1. European Heart Failure Self-Care Behaviors Scale [Baseline-6 months]

    The scale includes recognizing symptoms such as edema and weight gain, dyspnea, and fatigue associated with heart failure; It consists of 12 questions to measure self-care behaviors such as applying to a doctor and nurse for these symptoms, regular use of drugs, use of fluid and salt, treatment such as diet and exercise regimen and self-care behaviors such as weight monitoring and edema monitoring.

Secondary Outcome Measures

  1. Medication Compliance Notification Scale [Baseline-6 months]

    The total test score is obtained by summing the scores obtained from the scale items evaluating drug compliance. Scores from the scale range from 5 to 25. An increase in the obtained scores indicates compatibility, and a decrease in scores indicates inconsistency.

  2. Minnesota Life with Heart Failure Survey [Baseline-6 months]

    The scale measures the effect of physical and social functionality on heart failure, as well as assessing the effect of common physical symptoms such as shortness of breath, fatigue, peripheral edema, anxiety and depression symptoms. The 21-item scale is in a six-point Likert type (never=0, very little=1, little=2, a little=3, a lot=4, a lot=5). The lowest score that can be obtained from the scale is 0, and the highest score is 105.

  3. New York Heart Association classification (NYHA) [Baseline-6 months]

    Classification of the clinical picture according to the functional status of the patients, from 1 to 4, patients are classified according to their physical activities.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Have no communication barriers to affect cognitive functions,

  • Ejection-Fraction over 20

  • Diagnosed with Heart Failure for at least 6 months

  • Able to use tele-health applications (smartphone and application)

Exclusion Criteria:
  • Patients with communication difficulties

  • Patients who cannot use tele-health applications

Contacts and Locations

Locations

Site City State Country Postal Code
1 Harran University Şanlıurfa Türki̇ye Turkey 63000

Sponsors and Collaborators

  • Harran University

Investigators

  • Study Director: İbrahim C Di̇ki̇ci̇, MSc, Harran Üniversitesi
  • Study Chair: Medet Korkmaz, PhD, Inonu University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
İbrahim Caner Di̇ki̇ci̇, Lecturer, Harran University
ClinicalTrials.gov Identifier:
NCT05418478
Other Study ID Numbers:
  • 46811200
First Posted:
Jun 14, 2022
Last Update Posted:
Jun 14, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by İbrahim Caner Di̇ki̇ci̇, Lecturer, Harran University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 14, 2022